深部脑刺激术后住院时长与再入院的影响因素:单中心研究
该单中心回顾性研究分析了2016年10月至2024年9月397例DBS手术(388例患者),发现PD患者占73%,平均住院时长2.39±0.2晚;PD队列中高龄和抗凝药使用与住院延长相关,再入院率10.3%,多为感染或计划性再入院。
要点
- PD患者DBS术后高龄和使用抗凝药与住院时长增加相关。
- 再入院率10.3%,感染和计划性再入院为主因。
- PD队列再入院率6.9%,颅骨植入物使用是危险因素。
核心结论
- 高龄和抗凝药使用与PD患者DBS术后住院延长相关,颅骨植入物使用与PD患者再入院相关。
研究设计与样本
- 回顾性单中心研究,纳入2016年10月至2024年9月397例DBS手术(388例患者)。
主要发现
- PD患者占73%,特发性震颤占13%,平均住院时长分别为2.39±0.2晚和2.48±0.5晚。
- PD队列中高龄和抗凝药使用与住院时长增加相关,性别、UPDRS-3评分、症状时长和手术时间无统计学意义。
- 再入院率10.3%(41/397),其中感染20/41、计划性再入院13/41。
- 排除计划性再入院后,再入院平均住院时长13.4±0.6晚,多数再入院发生在出院后>30天(15/27)。
- PD队列再入院率6.9%(19/276),颅骨植入物使用是危险因素。
临床怎么用
- 可利用上述因素进行预康复、资源分配和患者咨询,以优化预后并降低治疗成本。
局限性
- 单中心回顾性设计,结果需在不同DBS技术和流程中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Deep Brain Stimulation (DBS) is a well-established treatment for refractory movement disorders. However, there are surgical risks and it often includes in-patient hospital admission. The aim is to review key factors associated with prolonged length of stay (LoS)(defined here as > 2 nights), and readmission within six months. METHODS: We retrospectively reviewed medical records of patients who underwent DBS insertion between October 2016 and September 2024 in our tertiary centre. Patient and operative factors were reviewed. RESULTS: 397 DBS procedures(388 patients) were included. Parkinson's disease (PD) patients constitute majority(73%), followed by Essential Tremor(13%). Mean LoS were 2.39 ± 0.2 and 2.48 ± 0.5 nights, respectively. Within PD cohort, older age and use of blood thinners were associated with increased LoS. Other factors such as gender, baseline Unified Parkinson's Disease Rating Scale-3 score, symptom duration, and operating time were not statistically significant. Readmission rate was 10.3%(41/397), with majority secondary to infection(20/41) or planned readmission(13/41). Excluding planned readmissions, average LoS during readmission was 13.4 ± 0.6 nights, with majority readmitted > 30 days post-discharge (15/27). Within PD, readmission rate was 6.9%(19/276), with skull-mounted implant use identified as risk factor. CONCLUSIONS: This study identified risk factors for prolonged hospital stay after DBS surgeries, with our surgical workflow, in a publicly-funded healthcare system. We also captured factors associated with readmission within six months, which is a much longer timeframe than most studies in literature. This provides information to facilitate prehabilitation, resource allocation, and patient counselling to optimise patient outcome and reduce treatment costs. Further studies are warranted to confirm these findings, especially with different DBS techniques and workflows.
引用
- Yuen J, Boyd E, Miller M, et al. What factors influence the length of stay and readmission after deep brain stimulation surgery? a tertiary centre study. Acta Neurochir (Wien). 2026. PMID: 41986786. doi:10.1007/s00701-026-06855-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。